Cite
HARVARD Citation
Ip, B. et al. (2022). Efficacy and safety of cilostazol in decreasing progression of cerebral white matter hyperintensities—A randomized controlled trial. Alzheimer's & dementia. 8 (1), p. n/a. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Ip, B. et al. (2022). Efficacy and safety of cilostazol in decreasing progression of cerebral white matter hyperintensities—A randomized controlled trial. Alzheimer's & dementia. 8 (1), p. n/a. [Online].